Comparison of hepatic resection and transarterial chemoembolization for UICC stage T3 hepatocellular carcinoma: a propensity score matching study

BACKGROUND: The optimal therapeutic strategy in UICC stage T3 hepatocellular carcinoma (HCC) patients that maximizes both safety and long-term outcome has not yet been determined. Our aim was to compare clinical outcomes following hepatic resection (HR) versus transarterial chemoembolization (TACE)...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:BMC Cancer
Auteurs principaux: Zhong, Chong, Zhang, Yong-Fa, Huang, Jun-Hai, Xiong, Cheng-Ming, Wang, Zi-Yu, Chen, Qing-Lian, Guo, Rong-Ping
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2018
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5992633/
https://ncbi.nlm.nih.gov/pubmed/29879928
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4557-5
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires